SCHEMBL13753151

SCHEMBL13753151

CC(C)NC(=O)c1cc(F)cc(C(F)(F)F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.63
MLYCD O95822 1/20 0.53
USP2 O75604 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
DDR1 Q08345 1/20 0.44
BDKRB1 P46663 3/20 0.43
TRPA1 O75762 1/20 0.43
NOTUM Q6P988 1/20 0.43
GAA P10253 1/20 0.43
CES2 O00748 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
CLPP Q16740 1/20 0.42
CYP2C19 P33261 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11955718 0.90 NPSR1 (0.71) NPSR1MLYCDUSP2CYP3A4CYP2C9
SCHEMBL13753427 0.88 NPSR1 (0.49) NPSR1MLYCDDDR1BDKRB1GAA
SCHEMBL13753586 0.85 NPSR1 (0.47) NPSR1MLYCDDDR1BDKRB1HDAC8
SCHEMBL13753667 0.84 HPGD (0.49) NPSR1DDR1
SCHEMBL13702129 0.84 MLYCD (0.55) NPSR1MLYCDCES2CYP1A2CYP2C19
SCHEMBL16261254 0.84 NPSR1 (0.63) NPSR1MLYCDUSP2CYP3A4CYP2C9
SCHEMBL13753284 0.84 MLYCD (0.58) NPSR1MLYCDDDR1BDKRB1TAS1R3
SCHEMBL12837589 0.84 NPSR1 (0.46) NPSR1DDR1BDKRB1NOTUMGAA
SCHEMBL13761365 0.83 NPSR1 (0.45) NPSR1DDR1BDKRB1GAACES2
SCHEMBL23237358 0.83 NPSR1 (0.61) NPSR1MLYCDCYP3A4DDR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
WO-2023039532-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-03-16 WO disclosed
WO-2021222556-A1 PI3K-α INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed